NationalunP2
This role involves leading the design, expansion, and functional testing of natural killer (NK) cell products for curative immune-based therapies targeting blood cancers and solid tumours. The position requires establishing and optimizing NK cell in vitro expansion platforms, conducting functional assays, and evaluating anti-tumour activity in pre-clinical mouse models. The successful candidate will translate research findings into publications, develop independent research plans, and mentor junior team members.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for NationalunP2.
NationalunP2 didn’t post a salary, so this is our estimate from similar listings.
20% above the average for this role